
Selvita S.A. — Investor Relations & Filings
Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Voting form | 2026-05-28 | English | |
| Supervisory Board's Resolutions | 2026-05-28 | English | |
| Remuneration report | 2026-05-28 | English | |
| Remuneration report-Auditor | 2026-05-28 | English | |
| Power of Attorney (natural person) | 2026-05-28 | English | |
| Power of Attorney (legal person) | 2026-05-28 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47864771 | Voting form | 2026-05-28 | English | ||
| 47864770 | Supervisory Board's Resolutions | 2026-05-28 | English | ||
| 47864769 | Remuneration report | 2026-05-28 | English | ||
| 47864768 | Remuneration report-Auditor | 2026-05-28 | English | ||
| 47864767 | Power of Attorney (natural person) | 2026-05-28 | English | ||
| 47864766 | Power of Attorney (legal person) | 2026-05-28 | English | ||
| 47864764 | Consolidated Financial Statements | 2026-05-28 | English | ||
| 47864763 | Sustainability Report - Auditor | 2026-05-28 | English | ||
| 47864762 | Consolidated Financial Report - Auditor | 2026-05-28 | English | ||
| 47864761 | Annual Report Sustainability Report | 2026-05-28 | English | ||
| 47864760 | Annual Report | 2026-05-28 | English | ||
| 47864758 | GSM Resolutions | 2026-05-28 | English | ||
| 47864757 | Convening | 2026-05-28 | English | ||
| 47864756 | Wniosek Zarządu - podział zysku / Allocation of profit resolution | 2026-05-28 | Polish | ||
| 47864755 | Uchwały Rady Nadzorczej | 2026-05-28 | Polish | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Selvita S.A., but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aptose Biosciences Inc.
Clinical-stage company developing targeted precision medici…
|
APS | CA | Professional, scientific and te… |
|
APURES CO., LTD.
Biotech firm providing MICROPIG models, bio-resources, and …
|
149300 | KR | Professional, scientific and te… |
|
Aran Research & Development (1982) Ltd.
A product design and development firm providing services fr…
|
ARAN | IL | Professional, scientific and te… |
|
Arch Biopartners Inc.
Developing novel drugs for acute kidney injury (AKI) and ch…
|
ARCH | CA | Professional, scientific and te… |
|
ARCHER MATERIALS LIMITED
Develops semiconductor devices for quantum computing and me…
|
AXE | AU | Professional, scientific and te… |
|
ARGENICA THERAPEUTICS LIMITED
Clinical-stage developer of neuroprotective drugs for acute…
|
AGN | AU | Professional, scientific and te… |
|
ARIUS Research Inc.
Discovery and development of targeted antibody therapeutics…
|
ARI | CA | Professional, scientific and te… |
|
AROVELLA THERAPEUTICS LIMITED
Develops off-the-shelf iNKT cell therapies for blood cancer…
|
ALA | AU | Professional, scientific and te… |
|
Artiva Biotherapeutics, Inc.
Develops allogeneic, off-the-shelf NK cell therapies for ca…
|
ARTV | US | Professional, scientific and te… |
|
ARVINAS, INC.
Clinical-stage biopharma developing therapeutics based on t…
|
ARVN | US | Professional, scientific and te… |
Selvita S.A. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/5808/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=5808 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=5808 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=5808 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 5808}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Selvita S.A. (id: 5808)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.